Celluris
PrivateLast Round
Seed
May 30, 2025
Total Funding Raised
$10.04M
Company Overview
Celluris is a biotechnology company that develops personalized CAR-T cell immunotherapy for the treatment of hematological and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celluris Comparables
Compare Celluris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellectis | 68% | |
| Recepta Biopharma | 66% | |
| Allogene Therapeutics | 61% | |
Celluris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2025 | ||||
| Grant | Nov 4, 2021 | ||||
| Accelerator | Nov 4, 2021 |
Celluris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BiotechTown | Seed, Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2021
Received funding from BiotechTown.
Celluris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Celluris's valuation, stock price, and market status.